Molbio Diagnostics Ltd
Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
01 / The disclosure
What the company shared
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
The evidence
Read the source excerpts
01Subject: Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Page 1
02This is to inform you that, Company is in receipt of disclosure from M/s India Business Excellence Fund III, a scheme of Business Excellence Trust III under Regulation 29 (2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as amended from time to time.
Page 1
03Enclosure: Disclosure received under Reg 29(2) of the SEBI(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 dated September 24,2026.
Page 1
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- c1129ed3-93a6-4c1a-8179-1f70c9970166
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 4 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- ffa1c94bc0bd02c58a8f3219d4bbe561c778e5f60da448da1d37de5faa93418d